We’re tracking in-house compensation. Take the Law360 Survey
Click here
USA v. DAGAR
-
September 05, 2025
The Second Circuit on Friday affirmed a former Pfizer Inc. statistician's insider trading conviction for making $272,000 in options trades from nonpublic news about the success of trials for the COVID-19 therapy drug Paxlovid, rejecting his arguments that prosecutors improperly shifted their legal theory at trial and pursued the case in the wrong venue.
-
August 06, 2024
A Manhattan federal judge sentenced a former Pfizer Inc. statistician from New Jersey to nine months in prison Tuesday after a jury convicted him of insider trading on secrets about his former company's COVID-19 therapy trials for an illegal $272,000 profit.
-
July 15, 2024
A former Pfizer employee argued that he shouldn't go to prison after a Manhattan federal jury convicted him of insider trading over clinical trial results for the drug Paxlovid, pointing out that a friend of his and co-defendant had dodged a custodial sentence in the case after helping prosecutors.
-
April 12, 2024
An electrical engineer was sentenced to probation Friday for trading Pfizer Inc.'s stock using confidential tips about the efficacy of its COVID-19 drug, after a Manhattan federal court recognized his decision to voluntarily assist prosecutors with the trial conviction of his friend, a former Pfizer employee who leaked insider information.
-
January 18, 2024
A former Pfizer employee was convicted by a Manhattan federal jury Thursday of trading on inside information about the company's COVID-19 drug Paxlovid.
-
January 17, 2024
A former Pfizer employee's failure to conceal his profitable trading related to the company's COVID-19 drug Paxlovid was "stupid," not exculpatory as his lawyers have claimed, a Manhattan federal prosecutor said Wednesday at the close of trial.
-
January 10, 2024
A former Pfizer employee accused of insider trading "gambled on options all the time," his attorney told a Manhattan federal jury on Wednesday, pointing to what he called a "giant hole" in the criminal case.
-
October 27, 2023
Prosecutors have told a Manhattan federal judge that data seized from a cellphone belonging to a former Pfizer employee they accuse of leaking clinical trial data for insider-trading purposes should be admissible in the fraud case.
-
October 19, 2023
A California man pled guilty in Manhattan federal court Thursday to trading on insider information about a trial of Pfizer's COVID-19 medicine Paxlovid.
-
September 29, 2023
A former Pfizer Inc. statistician and a computer engineer accused of trading on secret information about the company's Paxlovid COVID-19 therapy trials urged a Manhattan federal judge to suppress evidence the government obtained through search warrants they say contained "false and misleading" information.